SCHEMBL16410849

SCHEMBL16410849

CCC1(CC)C(N=NCc2ccc(S(=O)(=O)CN=[N+]=[N-])cc2)=Nc2ccccc2N1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410684 0.80 — —
SCHEMBL16410814 0.70 — —
SCHEMBL16410696 0.66 — —
SCHEMBL27742205 0.62 PSIP1 (0.48) —
SCHEMBL16410743 0.62 — —
SCHEMBL19426682 0.61 ALDH1A1 (0.52) —
SCHEMBL16410757 0.58 — —
SCHEMBL18634031 0.57 PLCG1 (0.53) —
SCHEMBL15212273 0.55 CA2 (0.37) —
SCHEMBL16410588 0.55 HSD11B1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback